{
  "id": 5435,
  "text": "Gynecol Oncol 2012;127:451-455.Available at: http://www.ncbi.nlm.nih.gov/pubmed/22986144.254.Garcia AA, Blessing JA, Vaccarello L, Roman LD.Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Gynecol Oncol 2012;127:451-455.Available at: http://www.ncbi.nlm.nih.gov/pubmed/22986144.254.Garcia AA, Blessing JA, Vaccarello L, Roman LD.Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "研究确实探讨了多西他赛（docetaxel）在治疗对传统疗法无效的宫颈鳞状细胞癌患者中的疗效。根据这项由妇科肿瘤小组进行的II期临床试验，研究评估了多西他赛在这些患者中的应用情况。这一研究意在寻找新的治疗方案，以提高对这些具有挑战性的癌症病例的应对效果。通过此试验，可以更好地了解多西他赛在此类癌症中的有效性和安全性。",
  "query": "根据text内容，包含\"docetaxel in refractory squamous cell carcinoma of the cervix\"，与宫颈癌相关。\n\n**问题：** 在治疗对传统疗法无效的宫颈鳞状细胞癌患者时，是否研究过使用多西他赛(docetaxel)的疗效？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据text内容，包含\"docetaxel in refractory squamous cell carcinoma of the cervix\"，与宫颈癌相关。\n\n**问题：** 在治疗对传统疗法无效的宫颈鳞状细胞癌患者时，是否研究过使用多西他赛(docetaxel)的疗效？\n\n<reference text>: Gynecol Oncol 2012;127:451-455.Available at: http://www.ncbi.nlm.nih.gov/pubmed/22986144.254.Garcia AA, Blessing JA, Vaccarello L, Roman LD.Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "研究确实探讨了多西他赛（docetaxel）在治疗对传统疗法无效的宫颈鳞状细胞癌患者中的疗效。根据这项由妇科肿瘤小组进行的II期临床试验，研究评估了多西他赛在这些患者中的应用情况。这一研究意在寻找新的治疗方案，以提高对这些具有挑战性的癌症病例的应对效果。通过此试验，可以更好地了解多西他赛在此类癌症中的有效性和安全性。"
}